Ebit 変化する 日付
AstraZeneca USD 3.16B 3.95B 2026-06
Genmab DKK 407M 221M 2026-06
GlaxoSmithKline GBP 2.6B 312M 2026-06
GRIFOLS EUR 428M 179M 2026-06
Hikma Pharmaceutical USD 348M 31M 2025-12
Lakefront Biotherapeutics EUR -43.51M 20.19M 2026-06
Qiagen NV USD 141.4M 44.52M 2026-06
UCB EUR 1.29B 571M 2025-12